QCIG
PVCT

Quad-Cities Investment Group’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Quad-Cities Investment Group’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,600
Closed -$1K – 826
2019
Q3 		$1K Hold
10,600
– – ﹤0.01% 833
2019
Q2 		$1K Hold
10,600
– – ﹤0.01% 832
2019
Q1 		$1K Hold
10,600
– – ﹤0.01% 826
2018
Q4 		$1K Hold
10,600
– – ﹤0.01% 845
2018
Q3 		$1K Hold
10,600
– – ﹤0.01% 837
2018
Q2 		$1K Buy
+10,600
New +$1K ﹤0.01% 842

Other funds holding PVCT

HFBOT
Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return
ACM
Academy Capital Management Waco, Texas $699M AUM 12.08% 1-Year Est. Return

Quad-Cities Investment Group's PVCT Position: Q4 2019 in Review

Quad-Cities Investment Group sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2019, closing a stake of 10,600 shares — an estimated $1K sold.

Quad-Cities Investment Group first reported a position in PVCT in Q2 2018 and held it in 6 quarters. The position peaked at $1K in Q3 2019. 3 funds tracked by Wall St. Rank hold PVCT as of Q4 2019.

  • Quad-Cities Investment Group reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2019 after selling out during the quarter.
  • Quad-Cities Investment Group sold 10,600 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2019, an estimated $1K.
  • Quad-Cities Investment Group first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2018 and held it in 6 quarters.
  • Quad-Cities Investment Group's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $1K in Q3 2019.
  • 3 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2019.

Based on Quad-Cities Investment Group's 13F filing for Q4 2019, filed 28 Jan 2020.